Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioCryst Pharmaceuticals Inc

+ Add to Watchlist

BCRX:US

10.1800 USD 0.5000 4.68%

As of 20:10:00 ET on 01/30/2015.

Snapshot for BioCryst Pharmaceuticals Inc (BCRX)

Open: 10.6400 Day's Range: 10.1600 - 10.7500 Volume: 877,670
Previous Close: 10.6800 52wk Range: 7.2900 - 14.6200 1-Yr Rtn: -0.20%

Stock Chart for BCRX

No chart data available.
  • BCRX:US 10.1800
  • 1D
  • 1M
  • 1Y
10.6800
Interactive BCRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BCRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6366
Est. EPS (USD) (12/2014) -0.7280
Est. PEG Ratio -
Market Cap (M USD) 731.57
Shares Outstanding (M) 71.86
30 Day Average Volume 902,285
Price/Book (mrq) 8.7658
Price/Sale (ttm) 33.3785
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BCRX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BCRX

BioCryst Pharmaceuticals, Inc. designs, optimizes and develops small-molecule novel pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases & cancer. The Company has late-stage compounds in development & continues to discover additional compounds & to progress them to meet the unmet medical needs of patients and physicians.

Jon P StonehousePresident/CEOThomas R Staab II "Tom"Senior VP/CFO/Acctg Ofcr
Lynne PowellSenior VP/Chief Commercial OfcrWilliam P SheridanSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for BCRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil